Hologic, Inc. $HOLX Stock Holdings Decreased by Black Creek Investment Management Inc.

Black Creek Investment Management Inc. lessened its stake in shares of Hologic, Inc. (NASDAQ:HOLX) by 7.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,743,345 shares of the medical equipment provider’s stock after selling 284,484 shares during the quarter. Hologic comprises approximately 11.9% of Black Creek Investment Management Inc.’s portfolio, making the stock its biggest position. Black Creek Investment Management Inc. owned about 1.68% of Hologic worth $252,638,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. The Manufacturers Life Insurance Company raised its position in Hologic by 294.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 11,022,455 shares of the medical equipment provider’s stock worth $718,223,000 after buying an additional 8,227,318 shares during the last quarter. Invesco Ltd. increased its stake in shares of Hologic by 72.5% during the second quarter. Invesco Ltd. now owns 8,340,785 shares of the medical equipment provider’s stock worth $543,486,000 after acquiring an additional 3,505,828 shares during the period. Norges Bank purchased a new position in Hologic during the second quarter worth about $180,055,000. Adage Capital Partners GP L.L.C. acquired a new stake in Hologic in the second quarter valued at about $48,283,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in Hologic by 28.1% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,767,813 shares of the medical equipment provider’s stock valued at $180,351,000 after purchasing an additional 606,782 shares in the last quarter. 94.73% of the stock is owned by institutional investors and hedge funds.

Hologic Price Performance

Shares of NASDAQ HOLX opened at $75.46 on Wednesday. The company has a current ratio of 4.04, a quick ratio of 3.32 and a debt-to-equity ratio of 0.48. The company’s 50-day moving average price is $74.98 and its 200 day moving average price is $72.27. Hologic, Inc. has a 52 week low of $51.90 and a 52 week high of $75.49. The stock has a market cap of $16.85 billion, a price-to-earnings ratio of 31.44, a PEG ratio of 2.25 and a beta of 0.73.

Hologic (NASDAQ:HOLX) last announced its quarterly earnings results on Thursday, January 29th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.09 by ($0.05). Hologic had a net margin of 13.18% and a return on equity of 19.58%. The business had revenue of $1.05 billion during the quarter, compared to analysts’ expectations of $1.07 billion. During the same period last year, the company earned $0.87 EPS. The firm’s revenue for the quarter was up 2.5% on a year-over-year basis. As a group, research analysts forecast that Hologic, Inc. will post 4.28 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

HOLX has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Hologic in a research note on Wednesday, January 28th. Morgan Stanley increased their price objective on Hologic from $69.00 to $76.00 and gave the stock an “equal weight” rating in a research report on Tuesday, November 11th. Needham & Company LLC reissued a “hold” rating on shares of Hologic in a report on Tuesday, November 4th. Argus cut shares of Hologic from a “buy” rating to a “hold” rating in a research note on Monday, January 12th. Finally, BNP Paribas Exane cut shares of Hologic from a “strong-buy” rating to a “hold” rating and set a $79.00 price objective for the company. in a research note on Friday, November 21st. Two equities research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Hologic currently has a consensus rating of “Hold” and an average price target of $78.42.

About Hologic

Hologic, Inc (NASDAQ: HOLX) is a global medical technology company specializing in women’s health. Headquartered in Marlborough, Massachusetts, the company develops and manufactures diagnostic products, imaging systems and surgical solutions designed to detect, diagnose and treat diseases with a primary focus on breast and skeletal health, gynecological conditions and molecular diagnostics. Its product portfolio includes digital mammography systems, 3D mammography solutions, bone densitometry equipment and molecular assays for infectious disease and oncology applications.

Since its founding in 1985, Hologic has grown through both internal innovation and strategic acquisitions.